Cholesteryl ester transfer in hypercholesterolaemia: Fasting and postprandial studies with and without pravastatin

Atherosclerosis

Volumn 141, Issue 1, 1998, Pages 87-98

  Contacos, Christine ^d   Barter, Philip J ^a,b,c   Vrga, Ljubica ^d   Sullivan, David R ^d  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d NONE

Author keywords

Cholesteryl ester transfer protein; Diet Atherogenic; HMG CoA reductase inhibitors; Lipoproteins LDL; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FAT INTAKE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 19244382100     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00151-8     Document Type: Article

References (41)

1. Glomset JA The plasma cholesterol:acyltransferase reaction. J Lipid Res. 9:1968;155-167.
2. Nichols AV, Smith L Effect of very low density lipoproteins on lipid transfer in incubated serum. J Lipid Res. 6:1965;206-210.
3. Tall AR Plasma cholesteryl ester transfer protein. J Lipid Res. 34:1993;1255-1274.
4. Fielding CJ, Fielding PE Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
5. Tato F, Vega GL, Tall AR, Grundy SM Relation between cholesterol ester transfer protein activites and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 15:1995;112-120.
6. Quinet E, Tall A, Ramakrishnan R, Rudel L Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest. 87:1991;1559-1566.
7. Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest. 79:1987;1217-1225.
8. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb. 11:1991;797-804.
9. Bagdade JD, Ritter MC, Davidson M, Subbaiah PV Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia. Arterioscler Thromb. 12:1992;1146-1152.
10. Guerin M, Dolphin PJ, Chapman MJ A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apo B-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma. Arterioscler Thromb. 14:1994;199-206.
11. Campos H, Genest JJJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 12:1992;187-195.
12. Coresh J, Kwiterovich POJ, Smith HH, Bachorik PS Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 34:1993;1687-1697.
13. Mann CJ, Yen FT, Grant AM, Bihain BE Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 88:1991;2059-2066.
14. McNamara JR, Jenner JL, Li Z, Wilson PW, Schaefer EJ Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb. 12:1992;1284-1290.
15. Superko HR, Krauss RM Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis. 95:1992;69-76.
16. Bagdade JD, Lane JT, Stone N, Ritter MC, Subbaiah PV Persistent abnormalities in lipoprotein composition and cholesteryl ester transfer following lovastatin treatment. J Lipid Res. 31:1990;1263-1269.
17. Ahnadi CE, Berthezene F, Ponsin G Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects. Atherosclerosis. 99:1993;219-228.
18. Guerin M, Dolphin PJ, Talussot C, Gardette J, Berthezene F, Chapman MJ Pravastatin modulates cholesteryl ester transfer from HDL to apo B-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol. 15:1995;1359-1368.
19. Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull WJ et al. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study. Atherosclerosis. 85:1990;81-89.
20. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. Am J Cardiol. 72:1993;1031-1037.
21. McTavish D, Sorkin EM Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs. 42:1991;65-89.
22. Weintraub MS, Eisenberg S, Breslow JL Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia. Eur J Clin Invest. 19:1989;480-485.
23. Tall A, Sammett D, Granot E Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest. 77:1986;1163-1172.
24. Castro GR, Fielding CJ Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest. 75:1985;874-882.
25. Brown AJ, Roberts DCK Moderate fish oil improves lipaemic response to a standard fat meal. A study in 25 healthy men. Arterioscler Thromb. 11:1991;457-466.
26. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
28. Wang XL, Dudman NPD, Wilcken DEL Enzyme-linked immunosorbent assay of apolipoprotein B in blood spotted onto filter paper, suitable for neonatal screening. Clin Chem. 35:1989;1000-1004.
29. Eto M, Watanabe K, Ishii K A rapid flat gel isoelectric focussing method for the determination of apo E phenotypes and its application. Clin Chim Acta. 149:1985;21-27.
30. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis. 7:1987;483-490.
31. Blanche PJ, Gong EL, Forte TM, Nichols AV Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta. 665:1981;408-419.
32. Groener JEM, Pelton RW, Kostner GM Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 32:1986;283-286.
33. Havel RJ, Eder HA, Bragdon JH The distribution of chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
34. Dobiasova M, Schutzova M Cold labelled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. Physiol Bohemoslov. 35:1986;319-327.
35. Jones B Design and Analysis of Cross-Over Trials. 1989;Chapman and Hill, London.
36. Armitage P, Berry G Statistical Methods in Medical Research. Second Ed. 1987;Blackwell, Oxford.
37. Eisenberg S, Bilheimer DW, Levy RI, Lindgren FT On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta. 326:1973;361-377.
38. Cheung MC, Austin MA, Moulin P, Wolf AC, Cryer D, Knopp RH Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. Atherosclerosis. 102:1993;107-119.
39. Dullaart RP, Groener JE, van Wijk H, Sluiter WJ, Erkelens DW Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. Arteriosclerosis. 9:1989;614-622.
40. Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, Sirtori CR, Franceschini G Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol. 15:1995;1819-1828.
41. Guerin M, Bruckert E, Dolphin PJ, Turpin G, Chapman MJ Fenofibrate reduces plasma cholesteryl ester from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidaemia. Arterioscler Thromb Vasc Biol. 16:1996;763-772.